Supplemental Table 1 and Figures related to the article "Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis" are available here.Supplemental Table 1: Malignancies, autoimmune or inflammatory diseases, and drug associated to eosinophilic fasciitis (AID)Supplemental Figure 1: Flow chart of the studySupplemental Figure 2: Multiple correspondence analysis derived dendrogram and factor map of 128 individuals highlighting the clustering of eosinophilic patient
Objectives: Eosinophilic skin infiltration may develop as a result of a variety of infectious, infla...
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-vessel necrotizing vascu...
International audienceTo determine the prevalence of eosinophilia in patients with recent-onset arth...
Contains fulltext : 177156.pdf (publisher's version ) (Closed access)BACKGROUND: E...
Systemic mastocytosis (SM) is frequently associated with eosinophilia. To examine its prevalence and...
BACKGROUND: Eosinophilic fasciitis (EF) is a connective tissue disease with an unknown long-term cou...
BACKGROUND: Eosinophilic fasciitis is a rare scleroderma-like illness. The clinical spectrum of the ...
Eosinophilic fasciitis is a rare disorder of unknown etiology and poorly understood pathogenesis. It...
OBJECTIVES: Eosinophilic fasciitis (EF) was described in 1974 by Shulman as a rare fibrosing connec...
Eosinophilic fasciitis is an uncommon disorder of unknown aetiology and poorly-understood pathogenes...
In 1997 the term eosinophil end-organ damage(EEOD) was introduced to facilitate management of patien...
Eosinophils and their products play an essential role in the pathogenesis of various reactive and ne...
Introduction: Blood eosinophilia (BE) is described as a poor prognosis marker for some T cell malign...
Objectives: Eosinophilic skin infiltration may develop as a result of a variety of infectious, infla...
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-vessel necrotizing vascu...
International audienceTo determine the prevalence of eosinophilia in patients with recent-onset arth...
Contains fulltext : 177156.pdf (publisher's version ) (Closed access)BACKGROUND: E...
Systemic mastocytosis (SM) is frequently associated with eosinophilia. To examine its prevalence and...
BACKGROUND: Eosinophilic fasciitis (EF) is a connective tissue disease with an unknown long-term cou...
BACKGROUND: Eosinophilic fasciitis is a rare scleroderma-like illness. The clinical spectrum of the ...
Eosinophilic fasciitis is a rare disorder of unknown etiology and poorly understood pathogenesis. It...
OBJECTIVES: Eosinophilic fasciitis (EF) was described in 1974 by Shulman as a rare fibrosing connec...
Eosinophilic fasciitis is an uncommon disorder of unknown aetiology and poorly-understood pathogenes...
In 1997 the term eosinophil end-organ damage(EEOD) was introduced to facilitate management of patien...
Eosinophils and their products play an essential role in the pathogenesis of various reactive and ne...
Introduction: Blood eosinophilia (BE) is described as a poor prognosis marker for some T cell malign...
Objectives: Eosinophilic skin infiltration may develop as a result of a variety of infectious, infla...
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-vessel necrotizing vascu...
International audienceTo determine the prevalence of eosinophilia in patients with recent-onset arth...